Sutro Biopharma (STRO) Stock Price, Quote, News & History

Q: What sector and industry does Sutro Biopharma (STRO) operate in?

Sutro Biopharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Comments

Sutro Biopharma Inc (STRO) Stock Price, Quote, News & History

STRONASDAQ

Logo brought to you by Benzinga Data

Trade with Public

$15.52

0.926.30%

At close: Feb 6, 4:00 PM EST

$15.44

-0.0806-0.52%

After Hours: Feb 6, 4:21 PM EST

Overview

News Earnings Options Analyst Ratings Insider Trades Short Interest Stock Report

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Key Statistics

Open

$14.85

Close

$15.52

Volume / Avg.

108.98K / 110.80K

Day Range

$14.27 - $16.24

52 Wk Range

5.23 - 21.25

Market Cap

$131.53M

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

61

Short Interest

6.24%

Days to Cover

4.03

Recent Sutro Biopharma Inc News

This Li Auto Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Monday

Avi Kapoor

Penny Stock Sutro Biopharma Cuts Costs, Refocuses Pipeline

Sutro Biopharma reported $62 million in 2024 revenue, down from $153.7 million in 2023, and announced a pipeline restructuring.

Vandana Singh

Dow Jumps Over 600 Points; US Consumer Sentiment Tumbles In March

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-222.53M

Investing Cash Flow (TTM)

113.80M

Financing Cash Flow (TTM)

84.00K

Free Cash Flow (TTM)

-225.11M

Capital Expenditure (TTM)

-2.58M

Net Change in Cash (TTM)

-108.65M

Analyst Trends and Forecast

1

Aug 25

1

Dec 25

0

Jan

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

3.0

Hold

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

-$18.39M

PE Ratio (TTM)

-

PE Ratio (FWD)

-

PEG Ratio (TTM)

-

PS Ratio (TTM)

1.16

PB Ratio (TTM)

-

Earnings Yield % (TTM)

-178.33%

Earnings Yield % (FWD)

-32.65%

EV / EBITDA (TTM)

-

Price / EBITDA (TTM)

-

Price / Free Cash Flow (TTM)

-

Book Value / Share

-$10.24

Company Debt

Total Debt

-

LT Debt

-

LT Debt Issuance (TTM)

-

LT Debt Repayment (TTM)

$0

Total Cash

$65.93M

Debt to Equity

-

Issuance of Debt (TTM)

$0

Repayment of Debt (TTM)

$0

Key Statistics

Open

$14.85

Close

$15.52

Volume / Avg.

108.98K / 110.80K

Day Range

$14.27 - $16.24

52 Wk Range

5.23 - 21.25

Market Cap

$131.53M

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

61

Short Interest

6.24%

Days to Cover

4.03

About

Sector

Health Care

Industry

Biotechnology

Sutro Biopharma Inc is a clinical-stage drug discovery, development, and manufacturing company. It is mainly engaged in the development of biopharmaceutical products. The company manufactures next-generation protein therapeutics for cancer and autoim...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

Q

How do I buy Sutro Biopharma (STRO) stock?

A

You can purchase shares of Sutro Biopharma (NASDAQ:STRO) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Sutro Biopharma (STRO) competitors?

A

Other companies in Sutro Biopharma’s space includes: Macrogenics Inc (NASDAQ:MGNX), Connect Biopharma Holdings Ltd (NASDAQ:CNTB), Korro Bio Inc (NASDAQ:KRRO), Inovio Pharmaceuticals Inc (NASDAQ:INO) and Elicio Therapeutics Inc (NASDAQ:ELTX).

Q

What is the forecast, or price target, for Sutro Biopharma (STRO) stock?

A

Sutro Biopharma has a consensus price target of $7.91.

Q

What is the current price for Sutro Biopharma (STRO)?

A

The stock price for Sutro Biopharma (NASDAQ: STRO) is $15.4394 last updated February 6, 2026 at 4:21 PM EST.

Q

Does Sutro Biopharma (STRO) pay a dividend?

A

There are no upcoming dividends for Sutro Biopharma.

Q

When is Sutro Biopharma (NASDAQ:STRO) reporting earnings?

A

Sutro Biopharma does not have any upcoming earnings scheduled.

Q

Is Sutro Biopharma (STRO) going to split?

A

There is no upcoming split for Sutro Biopharma.

Q

What sector and industry does Sutro Biopharma (STRO) operate in?

A

Sutro Biopharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

People Also Watch

Connect Biopharma Holdings Ltd

Inovio Pharmaceuticals Inc

NASDAQ:INO

$1.69

1.64%

Elicio Therapeutics Inc

NASDAQ:ELTX

$8.01

-3.73%

Fate Therapeutics Inc

NASDAQ:FATE

$1.13

-0.61%

Whitehawk Therapeutics Inc

NASDAQ:WHWK

$2.70

-2.17%

Sangamo Therapeutics Inc

NASDAQ:SGMO

$0.41

2.12%

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Key Statistics

Open

$14.85

Close

$15.52

Volume / Avg.

108.98K / 110.80K

Day Range

$14.27 - $16.24

52 Wk Range

5.23 - 21.25

Market Cap

$131.53M

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

61

Short Interest

6.24%

Days to Cover

4.03

Recent Sutro Biopharma Inc News

This Li Auto Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Monday

Avi Kapoor

Penny Stock Sutro Biopharma Cuts Costs, Refocuses Pipeline

Sutro Biopharma reported $62 million in 2024 revenue, down from $153.7 million in 2023, and announced a pipeline restructuring.

Vandana Singh

Dow Jumps Over 600 Points; US Consumer Sentiment Tumbles In March

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-222.53M

Investing Cash Flow (TTM)

113.80M

Financing Cash Flow (TTM)

84.00K

Free Cash Flow (TTM)

-225.11M

Capital Expenditure (TTM)

-2.58M

Net Change in Cash (TTM)

-108.65M

Analyst Trends and Forecast

1

Aug 25

1

Dec 25

0

Jan

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

3.0

Hold

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

-$18.39M

PE Ratio (TTM)

-

PE Ratio (FWD)

-

PEG Ratio (TTM)

-

PS Ratio (TTM)

1.16

PB Ratio (TTM)

-

Earnings Yield % (TTM)

-178.33%

Earnings Yield % (FWD)

-32.65%

EV / EBITDA (TTM)

-

Price / EBITDA (TTM)

-

Price / Free Cash Flow (TTM)

-

Book Value / Share

-$10.24

Company Debt

Total Debt

-

LT Debt

-

LT Debt Issuance (TTM)

-

LT Debt Repayment (TTM)

$0

Total Cash

$65.93M

Debt to Equity

-

Issuance of Debt (TTM)

$0

Repayment of Debt (TTM)

$0

Key Statistics

Open

$14.85

Close

$15.52

Volume / Avg.

108.98K / 110.80K

Day Range

$14.27 - $16.24

52 Wk Range

5.23 - 21.25

Market Cap

$131.53M

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

61

Short Interest

6.24%

Days to Cover

4.03

About

Sector

Health Care

Industry

Biotechnology

Sutro Biopharma Inc is a clinical-stage drug discovery, development, and manufacturing company. It is mainly engaged in the development of biopharmaceutical products. The company manufactures next-generation protein therapeutics for cancer and autoim...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry